Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000387690 | SCV000344523 | uncertain significance | not provided | 2016-08-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000387690 | SCV002412164 | likely benign | not provided | 2025-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002418135 | SCV002722137 | likely benign | Inborn genetic diseases | 2017-09-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003910036 | SCV004721071 | likely benign | RAI1-related disorder | 2020-07-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |